SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Technology StocksNuance Communications, Inc.


Previous 10 Next 10 
From: deeno8/11/2014 5:39:02 PM
   of 832
 
Another lousy report. what is Icahn thinking? Would have sold long ago, if I wasnt so curious.

Share RecommendKeepReplyMark as Last Read


From: Savant10/17/2014 12:16:40 AM
1 Recommendation   of 832
 
Siri & Nina & Dom, incestuous 3-some? forbes.com

with cuz AneedA thrown into the mix?

finance.yahoo.com

Share RecommendKeepReplyMark as Last Read


From: Savant11/24/2014 5:45:22 PM
   of 832
 
Nuance Communications, Inc. (NASDAQ: NUAN) today announced financial results for its fiscal 2014 and fourth quarter, ended September 30, 2014.

In fiscal 2014, Nuance reported GAAP revenue of $1,923.5 million, up 3.7% from $1,855.3 million in fiscal 2013. In fiscal 2014, Nuance reported non-GAAP revenue of $1,987.1 million, which includes $63.6 million of revenue lost to accounting treatment in conjunction with acquisitions. Fiscal 2014 non-GAAP revenue grew 1.5% over non-GAAP revenue of $1,957.7 million in fiscal 2013. In fiscal 2014, Nuance reported bookings of $2,441.9 million, up 27.4% from $1,916.5 million in fiscal 2013.

In fiscal 2014, Nuance recognized GAAP net loss of $(150.3) million, or $(0.47) per share, compared to GAAP net loss of $(115.2) million, or $(0.37) per share, in fiscal 2013. In fiscal 2014, Nuance reported non-GAAP net income of $360.1 million, or $1.12 per diluted share, compared to $428.0 million, or $1.33 per diluted share, in fiscal 2013. Nuance's fiscal 2014 non-GAAP operating margin was 23.7%, compared to 27.9% in fiscal 2013. Nuance reported cash flow from operations of $358.1 million, compared to $395.0 million in fiscal 2013. Nuance ended fiscal 2014 with total deferred revenue of $548.1 million, up 32.2% compared to $414.6 million a year ago. Nuance ended fiscal 2014 with $588.2 million in cash, cash equivalents and marketable securities.

In the fourth quarter of fiscal 2014, Nuance reported GAAP revenue of $502.3 million, up 6.4% from $472.2 million in the fourth quarter of fiscal 2013. Nuance reported non-GAAP revenue of $520.3 million, which includes $18.0 million of revenue lost to accounting treatment in conjunction with acquisitions, compared to $490.4 million in the fourth quarter of fiscal 2013. In the fourth quarter of fiscal 2014, Nuance reported bookings of $619.6 million, up 24.5% from $497.7 million in the fourth quarter of fiscal 2013.

In the fourth quarter of fiscal 2014, Nuance recognized GAAP net loss of $(1.5) million, or $(0.00) per share, compared to GAAP net loss of $(32.3) million, or $(0.10) per share, in the fourth quarter of fiscal 2013. In the fourth quarter of fiscal 2014, Nuance reported non-GAAP net income of $107.6 million, or $0.33 per diluted share, up from non-GAAP net income of $95.2 million, or $0.30 per diluted share, in the fourth quarter of fiscal 2013. Nuance's fourth quarter fiscal 2014 non-GAAP operating margin was 25.9%, up from 25.3% in the fourth quarter of fiscal 2013. Nuance reported cash flow from operations of $95.9 million in the fourth quarter of fiscal 2014, up 2.6% from $93.5 million in the fourth quarter of fiscal 2013.

Please refer to the "Discussion of Non-GAAP Financial Measures" and to the "GAAP to Non-GAAP Reconciliations," included elsewhere in this release, for more information regarding the company's use of non-GAAP measures.

Fourth Quarter and Fiscal Year Highlights

-- Bookings -- FY 14 bookings were $2,441.9 million, up 27.4% from $1,916.5 million in FY 13. FY 14 bookings exceeded our updated guidance range of $2.35 billion to $2.40 billion. -- Revenue -- Q4 14 non-GAAP revenue was $520.3 million, up 6.1% from $490.4 million a year ago. -- EPS -- Q4 14 non-GAAP EPS was $0.33 per diluted share, up from $0.30 per diluted share a year ago. -- Recurring revenue -- Recurring revenue increased from 52% of total non-GAAP revenue in FY 12 to 58% in FY 13 and to 64% in FY 14. Perpetual licenses decreased from 38% of total non-GAAP revenue in FY 12 to 32% in FY 13 and to 26% in FY 14. -- Deferred revenue -- Nuance ended FY 14 with total deferred revenue of $548.1 million, up 32% compared to $414.6 million at the end of FY 13. -- Operating cash flow -- FY 14 operating cash flow equaled 99% of non-GAAP net income, up from 92% in FY 13 and ahead of our target of 95%.

"We delivered a strong finish to fiscal 2014, with revenue, EPS and bookings above our guidance ranges. In fiscal 2014, recurring revenues represented 64% of total revenue, up 6 percentage points from last year, as we continue to transition our revenue model toward more stable, predictable recurring revenue streams. The positive deferred revenue and cash flow characteristics of our recurring revenue streams also continue to benefit the business. Fiscal 2014 bookings and execution in strategic markets position us well for a return to growth in fiscal 2015," said Tom Beaudoin, Nuance CFO.

Highlights from the quarter include:

-- Healthcare -- For Nuance's healthcare solutions, fourth quarter fiscal 2014 non-GAAP revenue was $238.3 million and FY 14 non-GAAP revenue was $942.7 million. Key customers in the quarter included Avera Health, BayCare, Cambridge Trusts, Cleveland Clinic, Froedtert, Group Memorial Health, Inova, Intermountain, Lahey, Providence, Scottsdale Health, and University of Colorado. -- Mobile & Consumer -- For Nuance's mobile and consumer solutions, fourth quarter fiscal 2014 non-GAAP revenue was $116.9 million and FY 14 non-GAAP revenue was $451.0 million. Key customers and OEM design wins in the quarter included Acer, AMD, AT&T, BMW, Bosch, Continental, Daimler, Fiat/Chrysler, Great Wall Motors, Harman Becker, Hisense, Honda, Mahindra, Melco, Motorola, Orange, Panasonic, Parrott, Rogers, Samsung, Scania, Shoretel, TCL, Telefonica, Volvo, and Yanfeng Visteon. -- Enterprise -- For Nuance's enterprise solutions, fourth quarter fiscal 2014 non-GAAP revenue was $95.6 million and FY 14 non-GAAP revenue was $357.1 million. Key customers in the quarter included American Airlines, Australia Department of Human Services, Banco Santander, Bank of America, Barclays, Citigroup, Delta Airlines, Delta Dental, Health Care Service Corporation, Jubilant FoodWorks (Domino's India), Public Service Enterprise Group, Talk Talk, Telstra, UnitedHealth Group, Wellpoint, and Wells Fargo Bank. -- Imaging -- For Nuance's document imaging solutions, fourth quarter fiscal 2014 non-GAAP revenue was $69.5 million and FY 14 non-GAAP revenue was $236.3 million. Key customers in the quarter included ABN Amro, Ashurst, Balabit, Barclays, Brother, Citigroup, CSC, Ernst & Young, HP, Laing Rourke, Neat, NOV, UPS and Visma.

Conference Call and Prepared Remarks

Nuance is providing a copy of prepared remarks in combination with its press release. These remarks are offered to provide shareholders and analysts with additional time and detail for analyzing results in advance of the company's quarterly conference call. The remarks will be available at nuance.com in conjunction with the press release.

As previously scheduled, the conference call will begin today, November 24, 2014 at 5:00 pm EST and will include only brief comments followed by questions and answers. The prepared remarks will not be read on the call. To access the live broadcast, please visit the Investor Relations section of Nuance's website at www.nuance.com. The call can also be heard by dialing (800) 230-1074 or (612) 234-9960 at least five minutes prior to the call and referencing code 340379. A replay will be available within 24 hours of the announcement by dialing (800) 475-6701 or (320) 365-3844 and using the access code 340379.

About Nuance Communications, Inc

Nuance Communications, Inc. (NASDAQ: NUAN) is a leading provider of voice and language solutions for businesses and consumers around the world. Its technologies, applications and services make the user experience more compelling by transforming the way people interact with devices and systems. Every day, millions of users and thousands of businesses experience Nuance's proven applications. For more information, please visit www.nuance.com.

Trademark reference: Nuance and the Nuance logo registered trademarks or trademarks of Nuance Communications, Inc. or its affiliates in the United States and/or other countries. All other trademarks referenced herein are the property of their respective owners.

Definitions

Bookings. Bookings represent the estimated gross revenue value of transactions at the time of contract execution, except for maintenance and support offerings. For fixed price contracts, the bookings value represents the gross total contract value. For contracts where revenue is based on transaction volume, the bookings value represents the contract price multiplied by the estimated future transaction volume during the contract term, whether or not such transaction volumes are guaranteed under a minimum commitment clause. Actual results could be different than our initial estimates. The maintenance and support bookings value represents the amounts billed in the period the customer is invoiced. Because of the inherent estimates required to determine bookings and the fact that the actual resultant revenue may differ from our initial bookings estimates, we consider bookings one indicator of potential future revenue and not as an arithmetic measure of backlog.

Recurring Revenue. Recurring revenue is the sum of recurring product and licensing, on-demand, and maintenance and support revenues as well as the portion of professional services revenue that is delivered under ongoing subscription contracts. Recurring Product and Licensing revenue is composed of term-based and ratable licenses as well as revenues from royalty arrangements.

Share RecommendKeepReplyMark as Last Read


From: Savant4/14/2015 1:53:53 AM
   of 832
 
Nuance, MEDITECH, IMO Collaboration to Automate Patient Problem Lists and Support Regulatory Reporting
Eases Reporting Burdens on Physicians through Efficient and Accurate Translation of the Patient Narrative into Discrete Data for EHRs

CHICAGO--(BUSINESS WIRE)--April 13, 2015--

Nuance Communications, Inc. (NASDAQ: NUAN) announced today a collaboration with Intelligent Medical Objects (IMO) and MEDITECH to take rich clinical narratives from physician notes, extract key facts as structured data and automatically populate patient problem lists and allergy lists using physician-friendly terminologies to preserve clinical intent of physician documentation in the EHR. This unique approach enables healthcare providers to translate unstructured narrative text into clinically-accurate, discrete data in the EHR to support patient problem lists for Meaningful Use as well as requirements for ICD-10 compliance, and quality reporting.

"This collaboration between Nuance, MEDITECH, and IMO is exciting because it will make it easier for doctors to efficiently create accurate, structured patient problem lists in the EHR and to comply with other documentation requirements that are useful to their healthcare system. It will allow doctors to stay focused on their patients and worry less about how to share their recommendations electronically within their work environment," says S. Luke Webster, M.D, vice president & CMIO, CHRISTUS Health.

This innovative process overcomes common problems physicians have creating problem lists in the EHR, providing efficiencies and relief through simply converting narrative created during physician documentation into real-time, actionable information for medical decision making:

-- Physicians can use Nuance Dragon Medical 360 real-time speech recognition or a mix of voice recognition and structured Physician Documentation sections to create a clinically-rich narrative at the point of care, which reflects the full patient's condition. -- Nuance's Clinical Language Understanding (CLU) engine analyzes the physician free text narrative and extracts key patient information, such as patient problems and allergies in real time as discrete, structured data. -- IMO(R)'s (iC) Intelligent Connect platform automatically maps this to IMO's terminology libraries, and to standardized code sets, thus preserving clinical intent while supporting clinical documentation standards for interoperability and continuity of care. -- The full patient story is then available in MEDITECH's EHR including structured data, unlocked from previously unstructured patient information, and this can now be analyzed and used for a variety of reporting and compliance measures including Meaningful Use, quality management and clinical decision making.

To learn more about this collaboration, please contact nuance@e-imo.com and visit Nuance (booth #1831), IMO (booth #3408) and MEDITECH (booth #6315) at the 2015 Health Information Management Systems Society (HIMSS15) Annual Conference in Chicago April 13-16. Nuance, IMO and MEDITECH will be launching an early adopter program to test this with healthcare providers.

Partner Quotes:

-- "MEDITECH is thrilled to collaborate with Nuance and IMO to give physicians the best possible documentation experience," says Helen Waters, MEDITECH vice president of sales and marketing. "Thanks to this fact extraction process, physicians can capture actionable clinical data, such as patient problems and allergies without changing workflow or taking any additional steps, further supporting our customers' ability to meet Meaningful Use and ICD-10 mandates, improve analytics, and ultimately better the entire patient experience, including patient outcomes." -- Frank Naeymi-Rad, Ph.D., chairman and CEO of IMO said: "This remarkable new solution shows how innovative thinking and a shared vision can deliver a new generation of clinical documentation that will allow our vendor-partners and clinical users to deliver the best patient care possible."

About IMO

Intelligent Medical Objects, Inc., (IMO) is the developer of the most widely-accepted medical terminology solution for the management of medical vocabularies and software applications at healthcare organizations worldwide. IMO's terminology is used by more than 3,000 hospitals and 3400,000 physicians daily, and this trusted terminology platform supports innovations by provider systems. IMO medical vocabulary and mapping products effectively capture clinical intent and help EMRs preserve and communicate this across the entire spectrum of care. IMO clinical terms are mapped to all standard coding systems including ICD-9, ICD-10 and SNOMED(R) , The accuracy of IMO's interface terminology was found to be 'nearly perfect' in an independent study published by the US Centers for Disease Control. Read more at www.e-imo.com. Follow @IMOsolutions on Twitter.

About MEDITECH

Today, more than 2,400 institutions worldwide use MEDITECH's fully integrated, interoperable EHR to provide healthcare to the communities they serve. Their robust, patient-centered technology spans the healthcare continuum, including unique functional capacity for the following environments: ambulatory care, acute care, long-term care, rehabilitation services, behavioral health, and home health care.

About Nuance Communications, Inc.

Nuance Communications, Inc. (NASDAQ: NUAN) is a leading provider of voice and language solutions for businesses and consumers around the world. Its technologies, applications and services make the user experience more compelling by transforming the way people interact with devices and systems. Every day, millions of users and thousands of businesses experience Nuance's proven applications. For more information, please visit: www.nuance.com. Connect with Nuance on social media through the healthcare blog, What's next, as well as Twitter and Facebook.

Nuance and the Nuance logo are trademarks or registered trademarks of Nuance Communications, Inc. or its affiliates in the United States and/or other countries. All other company names or product names may be the trademarks of their respective owners.

The statements in this press release relating to future plans, events or services, are forward-looking statements which are subject to specific risks and uncertainties. There are a number of factors which could cause actual events or results to differ materially from those indicated in such forward looking statements, including fluctuations in demand for the Nuance products, and the continued development of Nuance products. The reader is warned not to rely on these forward-looking statements without reservation, since these are simply reflections of the current situation. Nuance disclaims any obligation to update any forward-looking statements as a result of developments occurring after the date of this document.

Photos/Multimedia Gallery Available: businesswire.com

CONTACT: Nuance Communications, Inc.

Ann Joyal, 781-565-4155

ann.joyal@nuance.com

or

IMO

David Haines, 847-272-1242

press@e-imo.com

or

MEDITECH

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Savant who wrote (801)4/14/2015 1:54:59 AM
From: Savant
   of 832
 
Nuance to Showcase New Clinical Documentation Tools for Mobile Devices and Wearables
Joins Samsung at HIMSS to Preview New Dictation Capabilities on Samsung Gear S Watch

CHICAGO--(BUSINESS WIRE)--April 13, 2015--

Nuance Communications, Inc. (NASDAQ: NUAN) today announced that it will showcase its newest innovations for bringing clinical documentation to smart devices, smart watches and the Internet of Things at the 2015 Health Information Management Systems Society (HIMSS) Annual Conference.

In conjunction with this year's event, Nuance has announced PowerMic Mobile, which will be available in May 2015. This new mobile app can turn any iOS or Android mobile phone into a powerful and secure dictation device that allows physicians to easily dictate, edit, and navigate within the EHR simply by speaking. The app also provides physicians with flexibility in how and when they dictate information into patient records supporting a more convenient workflow.

In addition, recognizing the strong interest in smart watches and other personal devices, Nuance has teamed with Samsung to develop a use case for PowerMic Mobile that will allow physicians to dictate directly into an EHR using Dragon Medical 360 and the Samsung Gear S smart watch. Nuance and Samsung will showcase this innovation in their HIMSS booths, numbers 1831 and 7523, respectively.

"2015 has turned into the Year for the Internet of Things and the phenomenon is becoming firmly entrenched in healthcare," said Jonathon Dreyer, director of cloud and mobile solutions, Nuance Communications. "We are very excited to leverage our deep experience in this domain and to work with a pioneer such as Samsung to bring the power of voice to a new class of documentation tools that bridge conveniences found in clinicians' personal lives to the healthcare environment."

"Samsung is a pioneer in smart watches that are not just functional but stylish," said Ted Brodheim, vice president of Vertical Business at Samsung Electronics America. "Our Gear S like its predecessor smart watches, keeps health and fitness monitoring as a key feature, so this extension of Gear S to improve the healthcare experience is a natural partnership."

In addition to the Nuance PowerMic Mobile app and demonstration on the Samsung smart watch, Nuance will showcase several other mobile and IoT innovations in its Cloud and Mobility Pavilion, including:

-- Florence on Samsung Gear S smart watch: Nuance will demonstrate Florence, its intelligent virtual assistant, on a Samsung Gear S to show how this powerful tool can boost physician productivity through a smart watch. Florence provides a series of voice-driven clinical workflows that allow physicians to record vital signs, interact with patient alerts, document telephone encounters, and place medication, lab, and radiology orders. -- Surgical Glass: Using Nuance secure cloud-based medical speech recognition, Metrix Health's Glass wearable enables surgeons to document operative notes during care, helping to communicate these critically-important notes immediately rather than later from memory. The device provides heads-up display and secure medical dictation during surgery, helping to keep patients safe and improve the efficiency of surgeons.

About Samsung Business

As a global leader in enterprise mobility and information technology, Samsung Business provides a diverse portfolio of enterprise technologies from smartphones to wearables, tablets, digital displays, hospitality TVs, printers and medical diagnostic equipment. We are committed to putting the business customer at the core of everything we do by delivering comprehensive products, solutions and services across diverse industries including retail, healthcare, hospitality, education and government. Samsung Business is committed to helping customers realize the promise of a digital business. For more information, please visit samsung.com/business, call 1-866-SAM-4BIZ or follow Samsung Business via Twitter: @SamsungBizUSA.

About Nuance Communications, Inc.

Nuance Communications, Inc. (NASDAQ: NUAN) is a leading provider of voice and language solutions for businesses and consumers around the world. Its technologies, applications and services make the user experience more compelling by transforming the way people interact with devices and systems. Every day, millions of users and thousands of businesses experience Nuance's proven applications. For more information, please visit: www.nuance.com. Connect with Nuance on social media through the healthcare blog, What's next, as well as Twitter and Facebook.

Nuance and the Nuance logo are trademarks or registered trademarks of Nuance Communications, Inc. or its affiliates in the United States and/or other countries. All other company names or product names may be the trademarks of their respective owners.

The statements in this press release relating to future plans, events or services, are forward-looking statements which are subject to specific risks and uncertainties. There are a number of factors which could cause actual events or results to differ materially from those indicated in such forward looking statements, including fluctuations in demand for the Nuance products, and the continued development of Nuance products. The reader is warned not to rely on these forward-looking statements without reservation, since these are simply reflections of the current situation. Nuance disclaims any obligation to update any forward-looking statements as a result of developments occurring after the date of this document.

CONTACT: Nuance Communications, Inc.

Media Relations:

Ann Joyal, 781-565-4155

ann.joyal@nuance.com

or

Allison Galperin, 201-807-3144

agalperin@samsung.com

Share RecommendKeepReplyMark as Last Read


From: Savant4/23/2015 11:41:30 AM
   of 832
 
Nuance to Release Q2 FY 15 Results on May 7, 2015
BURLINGTON, Mass.--(BUSINESS WIRE)--April 23, 2015--

Nuance Communications, Inc. (NASDAQ: NUAN) today announced that the Company will release results for its second quarter ended March 31, 2015, after the market close on Thursday, May 7, 2015.

Nuance will provide a copy of prepared conference call remarks in combination with its press release. This process and these remarks are offered to provide shareholders and analysts additional time and detail for analyzing Nuance's results. The remarks will be available at www.nuance.com/earnings-results in conjunction with the press release.

The conference call will begin at 5:00 p.m. EDT and will include only brief comments followed by questions and answers. The prepared remarks will not be read on the call.

To access the live broadcast, please visit the Investor Relations section of Nuance's website at www.nuance.com. The call can also be heard by dialing (800) 230-1074 or (612) 234-9960 at least five minutes prior to the call and referencing code 358455. A replay will be available within 24 hours of the announcement by dialing (800) 475-6701 or (320) 365-3844 and using the access code 358455.

About Nuance Communications, Inc.

Nuance (NASDAQ: NUAN) is a leading provider of voice and language solutions for businesses and consumers around the world. Its technologies, applications and services make the user experience more compelling by transforming the way people interact with devices and systems. Every day, millions of users and thousands of businesses experience Nuance's proven applications. For more information, please visit www.nuance.com.

CONTACT: Nuance Communications, Inc.

For Investors

Kevin Faulkner, 408-992-6100

kevin.faulkner@nuance.com

or

For Press and Investors

Richard Mack, 781-565-5000

richard.mack@nuance.com

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Savant who wrote (803)4/25/2015 9:59:15 AM
From: Jorgen Jensen
   of 832
 
Finally showing some life, up a dollar the past 2 days on healthy volume

Share RecommendKeepReplyMark as Last Read


From: Jorgen Jensen5/11/2015 11:38:06 PM
   of 832
 
After a pretty good earnings report, targets have been raised to 22- by Oppenheimer, 18- by Canaccord, 20- by Craig Hallum and 18- by FBR and Co.

Share RecommendKeepReplyMark as Last Read


From: Jorgen Jensen5/13/2015 5:14:24 PM
   of 832
 
...and VETR investment firm lowered it's rating to Hold with a target of 17.68. I wonder how they arrived at that odd number.

Share RecommendKeepReplyMark as Last Read


From: Savant6/18/2015 12:00:31 PM
   of 832
 
Bank to use NUAN's voice biometrics for caller authentication

Share RecommendKeepReplyMark as Last Read
Previous 10 Next 10